🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Prostate › Texas › Austin

Qorannoo klinikaalii Kansarii Prostate Austin, TX keessatti

Qorannoo 15 Kansarii Prostate f Austin fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Namoota walitti qabaa jiraSadarkaa 1/2
  • New Experimental Therapeutics - NEXT Oncology, Austin
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04585750

Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial

Namoota walitti qabaa jira
  • Urology Austin, Austin
Umuriin 18 fi ol · Dhiroota · Haaromfame 28-Ful-2026 · NCT06496256

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • NEXT Oncology, Austin
Umuriin 18 fi ol · Dhiroota · Haaromfame 25-Ful-2026 · NCT06800313

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Namoota walitti qabaa jiraSadarkaa 3
  • Texas Oncology - Central/South Texas ( Site 8003), Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06136650

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Namoota walitti qabaa jiraSadarkaa 3
  • Urology Austin, Lakeway · Miili 16 fagaatti
Umuriin 18 hanga 100 · Dhiroota · Haaromfame 22-Ful-2026 · NCT06855277

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Austin
  • Research Site, Austin
Umuriin 18 fi ol · Dhiroota · Haaromfame 18-Ful-2026 · NCT06952803

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

Namoota walitti qabaa jiraSadarkaa 3
  • Urology Austin, PLLC - Research Department, Austin
Umuriin 18 fi ol · Dhiroota · Haaromfame 11-Ful-2026 · NCT06056830

PSMA PET Combined With MRI for the Detection of PCa

Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
  • Urology Austin, Austin
Umuriin 18 fi ol · Dhiroota · Haaromfame 23-Ado-2026 · NCT07052214

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Oncology Austin, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Elb-2026 · NCT07424547

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Oncology, Austin, TX 78758
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Elb-2026 · NCT06451497

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Elligo Health Research, Inc., Austin
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 20-Ama-2026 · NCT05366881

Sample Collection for Ongoing Research and Product Evaluation Study

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Natera, Inc., Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ama-2026 · NCT07318051

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Research Site 135, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Sad-2025 · NCT05914116

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Exelixis Clinical Site #4, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Ful-2025 · NCT05932862

Qorannoo Kansarii Prostate magaalota biroo keessatti

Qorannoo biroo Austin keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.